tm logo

Monitor this mark

View On USPTO

PIONEERING NEURONAL HEALTH
Live/Registered
REGISTERED

on 03 Dec 2024

Last Applicant/ Owned by

Protagenic Therapeutics, Inc.

149 Fifth Avenue, Suite 500

New York

NY

10010

Serial Number

97160401 filed on 07th Dec 2021

Registration Number

7589135 registered on 03rd Dec 2024

in the Principal Register

Correspondent Address

Erik M. Pelton

Erik M. Pelton

ARLINGTON, VA 22210

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

PIONEERING NEURONAL HEALTH

Pharmaceutical products for the treatment of stress, PTSD, depression anxiety, addiction, addiction withdrawal symptoms, brain functions, neuropsychiatric disorders, and neurodegenerative diseases

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical products for the treatment of stress, PTSD, depression anxiety, addiction, addiction withdrawal symptoms, brain functions, neuropsychiatric disorders, and neurodegenerative diseases

First Use Date in General

29th Aug 2023

First Use Date in Commerce

29th Aug 2023

Mark Details

Serial Number

No 97160401

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
03rd Dec 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
03rd Dec 2024REGISTERED-PRINCIPAL REGISTER
16th Feb 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
13th Feb 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13th Feb 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12th Feb 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10th Feb 2024STATEMENT OF USE PROCESSING COMPLETE
10th Feb 2024SOU EXTENSION 1 GRANTED
10th Feb 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
22nd Jan 2024NOTICE OF REVIVAL - E-MAILED